BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[BioDelivery Sciences International bolts higher on pending FDA approval]]>http://www.bloggingstocks.com/2009/06/15/biodelivery-sciences-international-bolts-higher-on-pending-fda-a/http://www.bloggingstocks.com/2009/06/15/biodelivery-sciences-international-bolts-higher-on-pending-fda-a/http://www.bloggingstocks.com/2009/06/15/biodelivery-sciences-international-bolts-higher-on-pending-fda-a/#commentsFiled under: ,

BioDelivery Sciences International Inc. (NASDAQ: BDSI) is bouncing higher today as investors anticipate FDA approval for its cancer pain drug. In a press release, the company said that it has reached an agreement with the Food & Drug Administration (FDA) and a review team on all aspects of the new drug application (NDA) for ONSOLIS. The regulatory agency informed BDSI that it "will not be issuing a review extension letter, as their action on the NDA is forthcoming."

"Although we cannot pinpoint the exact timing of when the FDA's action might occur, we have previously indicated that we expect a first half 2009 approval of the NDA for ONSOLIS. Based on our discussion with FDA last Friday, we should be within a few weeks of that target," explained Dr. Mark Sirgo, BDSI's president and CEO.

Continue reading BioDelivery Sciences International bolts higher on pending FDA approval

BioDelivery Sciences International bolts higher on pending FDA approval originally appeared on BloggingStocks on Mon, 15 Jun 2009 11:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>BDSIBioDelivery Sciences InternationalDr. Mark SirgointhenewsONSOLISshort sellersshort squeezetechnical analysisMon, 15 Jun 2009 11:20:00 EST